Search

everythinglearnresearchcommunity

for

Search:↓

Avicennia marina extract and avicequinone C can potentially promote hair growth and treat hair loss by interfering with hair loss mechanisms and boosting growth factors.

High amphiregulin in the skin is a bad sign for acute graft-versus-host disease.

A new method, iSiMPRe, effectively identifies key protein regions in cancer genes, highlighting potential drug targets.

IGFBP-rP1 could be a new treatment for a common type of hair loss.

CAP1 helps Arabidopsis plants grow better under ammonium stress.

Blocking CISD1 reduces hearing loss from cisplatin in mice.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Adiantum capillus extract reduces pain and swelling in animals.

Agouti and AGRP affect pigmentation and obesity, with implications for metabolic disorders.

Belatacept may be a promising treatment for alopecia areata.

NIPP1 is important for healthy skin and could help treat skin inflammation.

The new delivery system improves treatment for hair loss by enhancing drug absorption and effectiveness.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

The MBTPS2 gene variant c.970+5G>A is a common mutation causing IFAP syndrome.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

Activin A promotes ear hair cell development, while follistatin delays it.

ADM scaffolds help skin heal by promoting a healing-type immune response.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Blocking autophagy increases survival of inner ear hair cells exposed to gentamicin.

A new microneedle treatment shows promise for better hair regrowth in androgenetic alopecia.

Intravenous methylprednisolone helped over half of alopecia areata patients regrow hair, but many relapsed.

ASLNC168501 can help treat hair loss by restoring hair follicle stem cell function.

4-aminopyridine speeds up and improves skin wound healing.

Retinoic acid reduces cell damage from oxidative stress.

Invasomes effectively deliver drugs through the skin and have potential for improved treatments.

ASLNC168501 may help treat hair loss by boosting hair follicle stem cell activity.

MEGA PROTAC improves prediction and ranking of protein complexes better than existing methods.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

Aminoguanidine increases VEGF in stored hair micrografts, potentially improving their viability after transplant.